Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Alcohol and cancer: what clinicians need to know
A recent JAMA Insights article by Morford et al. highlights the strong link between alcohol…
A single genetic mutation may have made humans more vulnerable to cancer than chimpanzees
New research from the UC Davis Comprehensive Cancer Center, USA, has uncovered an evolutionary change…
GLP‑1 receptor agonist use and survival in older adults with cancer and type 2 diabetes
A large retrospective cohort study has found that glucagon-like peptide-1 receptor agonists (GLP-1RAs) are associated…
A technology that detects breast cancer relapses up to 5 years in advance has been developed
- Official BRACELET-1 trial results indicate that adding the oncolytic virus immunotherapy pelareorep to paclitaxel chemotherapy warrants further investigation in HR+ HER2- metastatic breast cancer
- More women can now get answers about their hereditary risk of breast and ovarian cancer due to new genetic method
- Racial differences in tumour collagen structure may impact cancer prognosis
The Oncology Journal Club Episode 19: San Antonio Breast Cancer Symposium
Detailed SABCS analysis with Eva Segelov, Craig Underhill, Steve Vogl and Amelia McCartney. The Oncology Podcast, brought to you by Oncology…
WCLC 2024: NeoCOAST-2 Data shows combination of Durvalumab with novel agents increases pathological responses in resectable NSCLC — Data builds on AEGEAN study research
- WCLC 2024: NeoCOAST-2 Data shows combination of durvalumab with novel agents increases pathological responses in resectable NSCLC
- WCLC 2024: Perioperative nivolumab may provide meaningful improvement in event-free survival compared to only neoadjuvant nivolumab plus chemotherapy for resectable NSCLC
- WCLC 2024: PanCan nodule management protocol more effective than LungRADSv1.1 method
It’s a myth that sunscreen prevents melanoma in people of colour: A dermatologist explains
Adewole S. Adamson, University of Texas at Austin Melanoma is a potentially deadly form of skin cancer that effects people…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.